Levonorgestrel 72657-0123
Product NDC
72657-0123- Manufacturer
- Glenmark Therapeutics Inc., Usa
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- February 9, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA207044
Active Ingredients
| Ingredient | Strength |
|---|---|
| Levonorgestrel | 1.5 mg/1 |
Drug Class
Progestin [EPC]Progestin-containing Intrauterine System [EPC]Inhibit Ovum Fertilization [PE]
Packaging Options(1)
1 BLISTER PACK in 1 CARTON (72657-123-11) / 1 TABLET in 1 BLISTER PACK